Antiarrhythmic trials: a decade of growth.
Kanjwal
M Y
MY
Department of Cardiac-Electrophysiology and Pacing, University School of Medicine, St. Elizabeth's Medical Centre, Boston, USA.
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D002423:Cause of Death; D017147:Defibrillators, Implantable; D005544:Forecasting; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000150:complications; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013015:Sotalol / Q000627:therapeutic use; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D013015:Sotalol; D000638:Amiodarone